Nazy Zomorodian
Overview
Explore the profile of Nazy Zomorodian including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
21
Citations
538
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Gu Y, Ly A, Rodriguez S, Zhang H, Kim J, Mao Z, et al.
Cell Rep Med
. 2024 Nov;
5(11):101824.
PMID: 39536751
Small cell neuroendocrine cancers share biologic similarities across tissue types, including transient response to platinum-based chemotherapy with rapid progression of disease. We report a phase 1b study of pembrolizumab in...
2.
Lloyd J, Zomorodian N, Devgan G, Batten J
Clin J Oncol Nurs
. 2024 Sep;
28(5):483-491.
PMID: 39324718
Background: About one-quarter of patients with advanced prostate cancer have alterations in homologous recombination repair (HRR) genes. In a global phase 3 study, talazoparib plus enzalutamide significantly improved progression-free survival...
3.
Faiena I, Comin-Anduix B, Berent-Maoz B, Bot A, Zomorodian N, Sachdeva A, et al.
J Immunother
. 2020 Sep;
43(9):273-282.
PMID: 32925563
Expression of carbonic-anhydrase IX (CAIX) in clear cell renal cell carcinoma (RCC) makes it an attractive vaccine target. We developed a fusion-gene construct, granulocyte-macrophage (GM) colony-stimulating factor+CAIX, delivered by an...
4.
Nickols N, Ganapathy E, Nguyen C, Kane N, Lin L, Diaz-Perez S, et al.
Prostate Cancer Prostatic Dis
. 2020 Jul;
24(1):135-139.
PMID: 32647353
Background: Hundreds of ongoing clinical trials combine radiation therapy, mostly delivered as stereotactic body radiotherapy (SBRT), with immune checkpoint blockade. However, our understanding of the effect of radiotherapy on the...
5.
Parikh N, Kishan A, Kane N, Diaz-Perez S, Ganapathy E, Nazarian R, et al.
Int J Radiat Oncol Biol Phys
. 2020 Jun;
108(4):930-935.
PMID: 32562839
Purpose: This study aimed to evaluate the feasibility and safety of prostate stereotactic body radiation therapy (SBRT) neoadjuvant to radical prostatectomy (RP) in a phase 1 trial. The primary endpoint...
6.
Birkhauser F, Pantuck A, Rampersaud E, Wang X, Kroeger N, Pouliot F, et al.
Cancer J
. 2013 May;
19(3):189-96.
PMID: 23708063
Purpose: To analyze the outcomes of patients with metastatic renal cell carcinoma treated with salvage-targeted therapy after progressing on high-dose interleukin (IL)-2 immunotherapy in a tertiary referral center. Materials And...
7.
Kroeger N, Seligson D, Klatte T, Rampersaud E, Birkhauser F, Rao P, et al.
Eur Urol
. 2012 Jan;
61(5):888-95.
PMID: 22269604
Background: While it is well known that clear cell renal cell carcinoma (ccRCC) that presents with lymphatic spread is associated with an extremely poor prognosis, its molecular and genetic biology...
8.
Kroeger N, Rampersaud E, Patard J, Klatte T, Birkhauser F, Shariat S, et al.
J Urol
. 2011 Dec;
187(2):418-23.
PMID: 22177164
Purpose: While microvascular invasion is an accepted risk factor in various cancers, its prognostic role in renal cell carcinoma is still unclear. Therefore, a large multicenter study examining the experience...
9.
Kroeger N, Klatte T, Birkhauser F, Rampersaud E, Seligson D, Zomorodian N, et al.
Cancer
. 2011 Oct;
118(7):1795-802.
PMID: 21997347
Background: Tobacco use is a leading cause of premature death, yet few studies have investigated the effect of tobacco exposure on the outcome of patients with renal cell carcinoma (RCC)....
10.
Klatte T, Said J, Seligson D, Rao P, de Martino M, Shuch B, et al.
J Urol
. 2010 Nov;
185(1):30-5.
PMID: 21074210
Purpose: Papillary renal cell carcinoma is characterized histologically by tumors with cells arranged in a papillary pattern. Typically the cells have a chromophilic appearance but areas may show cells with...